These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer. Maia S; Cardoso M; Paulo P; Pinheiro M; Pinto P; Santos C; Pinto C; Peixoto A; Henrique R; Teixeira MR Fam Cancer; 2016 Jan; 15(1):111-21. PubMed ID: 26289772 [TBL] [Abstract][Full Text] [Related]
4. Pan-cancer Analysis of Homologous Recombination Repair-associated Gene Alterations and Genome-wide Loss-of-Heterozygosity Score. Westphalen CB; Fine AD; André F; Ganesan S; Heinemann V; Rouleau E; Turnbull C; Garcia Palacios L; Lopez JA; Sokol ES; Mateo J Clin Cancer Res; 2022 Apr; 28(7):1412-1421. PubMed ID: 34740923 [TBL] [Abstract][Full Text] [Related]
5. Germline mutations in homologous recombination repair genes among Chinese pancreatic ductal adenocarcinoma patients detected using next-generation sequencing. Jiang H; Huang F; Chen X; Zhang L; Shen M; Pan B; Wang B; Guo W Mol Genet Genomic Med; 2023 Jul; 11(7):e2170. PubMed ID: 36978154 [TBL] [Abstract][Full Text] [Related]
6. Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations. Kim J; Jeong K; Jun H; Kim K; Bae JM; Song MG; Yi H; Park S; Woo GU; Lee DW; Kim TY; Lee KH; Im SA Hum Genomics; 2023 Jan; 17(1):2. PubMed ID: 36604691 [TBL] [Abstract][Full Text] [Related]
7. Homologous Recombination Deficiencies and Hereditary Tumors. Yamamoto H; Hirasawa A Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008774 [TBL] [Abstract][Full Text] [Related]
8. Homologous recombination repair gene mutations in Chinese localized and locally advanced prostate cancer patients. Jiang X; Hu X; Gu Y; Li Y; Jin M; Zhao H; Gao R; Huang Z; Lu J Pathol Res Pract; 2021 Aug; 224():153507. PubMed ID: 34102435 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions. Su Y; Yao Q; Xu Y; Yu C; Zhang J; Wang Q; Li J; Shi D; Yu B; Zeng Y; Zhu X; Bai Q; Zhou X Front Genet; 2021; 12():674094. PubMed ID: 34917121 [No Abstract] [Full Text] [Related]
10. Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers. Domagala P; Jakubowska A; Jaworska-Bieniek K; Kaczmarek K; Durda K; Kurlapska A; Cybulski C; Lubinski J PLoS One; 2015; 10(6):e0130393. PubMed ID: 26083025 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast Cancers. Huang CC; Tsai YF; Liu CY; Lien PJ; Lin YS; Chao TC; Feng CJ; Chen YJ; Lai JI; Phan NN; Hsu CY; Chiu JH; Tseng LM Ann Surg Oncol; 2022 Jun; 29(6):3578-3590. PubMed ID: 35226219 [TBL] [Abstract][Full Text] [Related]
13. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals. Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067 [TBL] [Abstract][Full Text] [Related]
14. Multi-Gene Next-Generation Sequencing Panel for Analysis of Maloberti T; De Leo A; Coluccelli S; Sanza V; Gruppioni E; Altimari A; Zagnoni S; Giunchi F; Vasuri F; Fiorentino M; Mollica V; Ferrari S; Miccoli S; Visani M; Turchetti D; Massari F; Tallini G; de Biase D Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240284 [TBL] [Abstract][Full Text] [Related]
15. A comprehensive literature review and meta-analysis of the prevalence of pan-cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies. Shao C; Wan J; Lam FC; Tang H; Marley AR; Song Y; Miller C; Brown M; Han J; Adeboyeje G Environ Mol Mutagen; 2022 Jul; 63(6):308-316. PubMed ID: 36054589 [TBL] [Abstract][Full Text] [Related]
16. Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer. Okawa Y; Iwasaki Y; Johnson TA; Ebata N; Inai C; Endo M; Maejima K; Sasagawa S; Fujita M; Matsuda K; Murakami Y; Nakamura T; Hirano S; Momozawa Y; Nakagawa H J Hepatol; 2023 Feb; 78(2):333-342. PubMed ID: 36243179 [TBL] [Abstract][Full Text] [Related]
17. Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas. Pennington KP; Walsh T; Harrell MI; Lee MK; Pennil CC; Rendi MH; Thornton A; Norquist BM; Casadei S; Nord AS; Agnew KJ; Pritchard CC; Scroggins S; Garcia RL; King MC; Swisher EM Clin Cancer Res; 2014 Feb; 20(3):764-75. PubMed ID: 24240112 [TBL] [Abstract][Full Text] [Related]
19. Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland. Wokołorczyk D; Kluźniak W; Huzarski T; Gronwald J; Szymiczek A; Rusak B; Stempa K; Gliniewicz K; Kashyap A; Morawska S; Dębniak T; Jakubowska A; Szwiec M; Domagała P; Lubiński J; Narod SA; Akbari MR; Cybulski C; Int J Cancer; 2020 Nov; 147(10):2793-2800. PubMed ID: 32875559 [TBL] [Abstract][Full Text] [Related]
20. Mutation status of RAD51C, PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations. Sato K; Koyasu M; Nomura S; Sato Y; Kita M; Ashihara Y; Adachi Y; Ohno S; Iwase T; Kitagawa D; Nakashima E; Yoshida R; Miki Y; Arai M Cancer Sci; 2017 Nov; 108(11):2287-2294. PubMed ID: 28796317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]